Steven Cohen Ikena Oncology, Inc. Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.46 - $6.0 $2.27 Million - $3.93 Million	654,800 Added 95.08%	1,343,496 $4.77 Million
Q2 2022 Aug 15, 2022	BUY	$3.23 - $7.4 $1.1 Million - $2.52 Million	340,000 Added 97.51%	688,696 $3.05 Million
Q1 2022 May 16, 2022	BUY	$5.61 - $13.85 $1.96 Million - $4.83 Million	348,696 New	348,696 $2.13 Million

30.6M

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $55.5M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.